mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.02 |